Market revenue in 2023 | USD 3,032.2 million |
Market revenue in 2030 | USD 4,794.5 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Fresh Donor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.39% in 2023. Horizon Databook has segmented the Japan in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
The IVF market in Japan holds high growth potential owing to the presence of a defined regulatory framework and introduction of newer techniques, such as AUGMENT. Japan witnessed an increase in the prevalence of infertility, which contributed to the growth of the IVF market.
Factors such as delayed marriages, lifestyle changes, and a decrease in the birth rate led to a higher demand for fertility treatments. Furthermore, the government of Japan recognized the importance of fertility treatments and implemented policies & initiatives to support IVF.
Financial assistance programs, tax incentives, and insurance coverage for certain aspects of IVF treatment are available to eligible individuals, reducing the financial burden of fertility treatments. For instance, in April 2022, Japan launched its national health insurance scheme, which would reimburse infertility treatments.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into Japan in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account